euretina logo European Society of Retina Specialists

Free Paper Sessions

AMD II

Friday 15 May
08:00 – 10:00

Presentations are 6 minutes in duration, followed by 2 minutes discussion

Venue: Clio/ Thalie

Chairpersons: U. Introini ITALY  A. Lowenstein ISRAEL

08:00 C. Kalogeropoulos  A. Nikolou  M. Aspiotis   GREECE
Macular Drusen quantification: A mathematical computer-assisted approach to correlate with Age-related Macular Degeneration (AMD) evolution
08:08 J. Kaluzny  B. Sikorski  D. Bukowska  M. Szkulmowski  M. Wojtkowski  A. Kowalczyk   POLAND
Confluent Drusen in Age-related Macular Degeneration accompanied by fluid under the sensory retina
08:16 I. Krebs  C. Glittenberg  J. Sebag  S. Binder   AUSTRIA
The vitreo-macular interface in Age-related Macular Degeneration
08:24 A. Lowenstein  Y. Lang   ISRAEL
Frequency of usage of the ForeseeHome, a home perimeter for early detection of choroidal neovascularization
08:32 L. Mendonca  M. Falcao  S. Fonseca  E. Brandao  F. Falcao-Reis  A. Carneiro   PORTUGAL
Anti-Vascular Endothelial Growth Factor (VEGF) therapy for Retinal Angiomatous Proliferation (RAP)
08:40 U. Introini  M. Setaccioli  F. Scotti  S. Giatsidis  L. Pierro  M. Gagliardi   ITALY
Spectral domain Optical Coherence Tomography evaluation of macular morphology after antiangiogenic treatment of Age-related Macular Degeneration
08:48 N. Eter  C. H. Meyer  F. G. Holz  W. Amoaku   GERMANY
12-month results of the SUSTAIN study: Safety and efficacy of ranibizumab treatment in patients with neovascular Age-related Macular Degeneration
08:56 I. Mantel  A. Ambresin  L. Konstantinidis   SWITZERLAND
Unusual pigment ephithelium tears after intravitreal ranibizumab treatment: Incidence in AMD with predominantly classic CNV
09:04 P. Hasler  S. Bloch  J. Villumsen  M. La Cour  H. Lund-Andersen  M. Larsen   SWITZERLAND
Safety of standardized intravitreal ranibizumab injection procedure mainly performed by inexperienced ophthalmologists at a referral clinic in Denmark
09:12 K. Hatz  U. Schneider  P.B. Henrich  B. Braun  S. Sacu  C. Prünte   SWITZERLAND
Comparing ranibizumab monotherapy and ranibizumab combined with standard verteporfin photodynamic therapy in neovascular Age-related Macular Degeneration: 1 year results
09:20 S. Karunanithi   INDIA
Real world experience of using pegaptanib sodium for treatment of exudative Age-related Macular Degeneration (AMD)
09:28 H. Kaymak  G. Mohammad  U. Mester   GERMANY
Is PDT still useful?
09:36 S. Kaynak  A. Selim  N. Kocak   TURKEY
Comparative study on photodynamic monotherapy and photodynamic therapy with IVTA + anti-VEGF triple management in Age-related Macular Degeneration
09:44 M. Maier  N. Feucht  J. Cabrerizo  C. Lohmann  I. Lanzl   GERMANY
Effect of intravitreal anti-VEGF agents on the vascular microstructure of the foveal avascular zone in patients with macular disease due to DME or BRVO
09:52 T. Jackson  M. Farah  J.P. Duprat  M. Avila  G.Y. Fujii  A. Santos   UNITED KINGDOM
Selective epiretinal brachytherapy for the treatment of choroidal neovascularisation associated with Age-related Macular Degeneration (AMD): 18 month visual results

Imaging

Friday 15 May
11:00 – 12:30

Presentations are 6 minutes in duration, followed by 2 minutes discussion

Venue: Clio/ Thalie

Chairpersons: A. Erginay FRANCE J. Fujimoto USA

11:00 A. Erginay  J.A. Pournaras  A. Gaudric  P. Massin   FRANCE
Comparison of the Optos P200C and Topcon TRC-NW6S in the screening of diabetic retinopathy
11:08 P. Wilson  J. Ellis  A. Ellingford  J. Talbot  C. MacEwen  G. Leese   UNITED KINGDOM
Screening for diabetic retinopathy: A comparative trial of biomicroscopy, photography and scanning laser ophthalmoscopy
11:16 J. Fujimoto  B. Potsaid  Y. Chen  J. Liu  J. Schuman  J. Duker   USA
Ultrahigh speed imaging with spectral and swept source fourier domain OCT
11:24 K. Gocho-Nakashima  N. Massamba  O. Roche  J.F. Le Gargasson  G. Soubrane  J.L. Dufier   FRANCE
Cone mosaic imaging using a new adaptive optics Fundus camera system
11:32 M. Karolczak-Kulesza  M. Pietryga  A. Brazert  J. Kociecki  J. Brazert  M. Brazert   POLAND
Doppler ultrasonography of eyeball and orbit blood vessels in fetus: Diagnostic possibilities (preliminary report)
11:40 D. Koleva-Georgieva  N. Sivkova   BULGARIA
En-face optical coherence tomography for evaluating pathological changes of the retina and vitreoretinal interface in eyes with diabetic macular edema
11:48 S. Schmitz-Valckenberg  L. Guo  A. Wegener  A. Tufail  F. G. Holz  F. Cordeiro   GERMANY
Localization and significance of in vivo near-infrared autofluorescent signal in retinal imaging
11:56 C. Schütze  C. Ahlers  G. Mylonas  R. Sayegh  R. Dunavoelgyi  U. Schmidt-Erfurth   AUSTRIA
Evaluation of morphology and extension of geographic atrophy by high resolution Optical Coherence Tomography (OCT) techniques
12:04 K. Hodjatjalali  H. Faghihi   IRAN
Ultrasound biomicroscopy study of vitreous incarceration after intravitreal injection of drug
12:12 R. Halfeld Furtado De Mendonça  L.C Pereira Vilanova  S. Rosemberg  L.M Guimarăes Santos   ITALY
Electroretinographic and ultra-structural findings in neuronal ceroid lipofucinosis in a Brazilian Indian tribe from the Amazon jungle
12:20 R. Sato  M. Nozaki  Y. Ogura   JAPAN
Influence of scleral buckling surgery on higher-order wavefront aberrations

Anterior/Posterior Segment Surgery & AMD

Friday 15 May
14:30 – 16:00

Presentations are 6 minutes in duration, followed by 2 minutes discussion

Venue: Clio/ Thalie

Chairpersons: C. Ahlers AUSTRIA  L. Arias SPAIN

14:30 C. Ahlers  I. Golbaz  G. Stock  R. Dunavölgyi  S. Sacu  U. Schmidt-Erfurth   AUSTRIA
Identification of optical density ratios in subretinal fluid as a clinically relevant biomarker in exudative macular disease
14:38 B. Dugas  R. Ouled-Moussa  P.O. Lafontaine  J.P. Berrod  A. Bron  C. Creuzot-Garcher   FRANCE
Idiopathic epiretinal macular membrane and cataract extraction: Combined vs consecutive surgery
14:46 S. Saliba  D. Ivastinovic  N. Ardjomand  M. Velikay- Parel  A. Wedrich   AUSTRIA
Endothelial cell loss in vitro after limbal silicone oil removal in porcine eyes
14:54 J. Yepez  J. Cedeno de Yepez   VENEZUELA
Dynamic of the fluid in the anterior chamber: Its possible role in vitreoretinal detachment after phacoemulsification of cataract
15:02 X. Yang   CHINA
Endoscopic vitrectomy utilized in severely traumatized eyes without light perception
15:10 T. Bagdasarova   RUSSIA
Treatment of retinoschisis by new segment-oval implants
15:18 A. Shaarawy   EGYPT
The effect of intravitreal triamcinolone injection during conventional retinal detachment on postoperative foveal architecture using Optical CoherenceTomography
15:26 L. Arias  J. Monés   SPAIN
Transconjunctival sutureless vitrectomy combined with rtPA injection and intravitreal bevacizumab in the treatment of hemorrhagic macular degeneration
15:34 A. Ambresin  L. Konstantinidis  L. Zografos  I. Mantel   SWITZERLAND
Intravitreal ranibizumab injection for the treatment of large submacular hemorrhage due to neovascular Age-related Macular Degeneration
15:42 N. Taneja  S. Jalali  S. Jan  J. Kenneth   INDIA
Clinical presentation, microbiological flora, and treatment outcomes after surgical removal of retained vegetative intraocular foreign body

Vitreoretinal Surgery II

Friday 15 May
16:30 – 18:06

Presentations are 6 minutes in duration, followed by 2 minutes discussion

Venue: Hermes

Chairpersons: S. Kant INDIA  G. Levitska UKRAINE

16:30 S. Kant  K. Anthony  U. Singh  B.D Bhatia   INDIA
Pattern of ROP and correlation with insulin-like growth factor-1
16:38 N. Lopes  M.P. Gomes  B.B. Pessoa  N. Ferreira  A. Meireles   PORTUGAL
Tomographic macular evaluation in unsatisfying visual recovery after primary vitrectomy for rhegmatogenous retinal detachment
16:46 G. Levitska  N. Pasyechnikova  S. Rodin  V. Naumenko  A. Korol   UKRAINE
Selective laser coagulation of the retinal pigment epithelium in treatment of residual macular detachment after surgery of rhegmatogenous retinal detachment
16:54 P. Kolar  D. Vizdova  D. Vyslouzilova   CZECH REPUBLIC
Pars plana vitrectomy for treatment of idiopathic macular epiretinal membranes
17:02 Z. Koshy  M. Das  M. Popiela   UNITED KINGDOM
20 gauge transconjunctival sutureless vitrectomy: Technique and audit of the first 120 cases
17:10 T. Josifova  P.B. Henrich  W. Schrader   SWITZERLAND
Relexing retinotomy: A method of choice
17:18 T. Imshenetskaya  V. Yarmak   BELARUS
Supporting encircling band with scleral buckling in the management of primary rhegmatogenous retinal detachment complicated by PVR: Right for life?
17:26 A. Lyssek-Boron  E. Wylegala  D. Dobrowolski  S. Teper   POLAND
Pars plana vitrectomy for failed scleral buckling
17:34 F. C. Miassi  C. Mateo  B. Corcostegui  R. Navarro   SPAIN
Macular buckling in the treatment of persistent macular hole without retinal detachment in high myopes
17:42 O. Okonkwo  K. Hassan  O. Oderinlo  F. Oluyadi  A. Ogunro  M. Ulaikere   NIGERIA
Trans scleral cyclophotocoagulation using the 810 diode laser in post vitrectomized eyes with elevated intraocular pressure
17:50 S. Priglinger  R. Strauss  C. Alge-Priglinger  M. Dirisamer  P. Henrich  C. Haritoglou   AUSTRIA
Brilliant Blue G assisted macular surgery
17:58 M. Romano  J. Marticorena  T. Stappler  H. Heimann  C. Sheridan  D. Wong   ITALY
Perioperative bevacizumab injection: Clinical and histological results

 

Back to previous page

Nice Congress Links

General Information

Speaker Zone

Programme Overview (pdf)

Special Events

Main Sessions

Other Sessions

71st Retinal Detachment Course

Uveitis Course

Instructional Courses

NEW - Free Paper Sessions

Poster Presentations

Surgical Skills Training Courses

Continuous Video Programme

EuroTimes Satellite Education Programme

Visa Letter Application

AV Instructions for Speakers

Abstract Submission

Hotel Booking

Registration Information